Understanding our eugenic past to take steps towards scientific accountability
By Rori Rohlfs,
Genes to Genomes
| 06. 08. 2020
Because genetic determinism is an implicit and stealth component of our academic inheritance, even well-meaning scientists working at respected institutions can unwittingly pursue research that supports eugenicist arguments.
I was a fourth-year graduate student when I found myself asking a librarian for the archives of the journal The Annals of Eugenics. I got to that point by climbing back through a chain of references on fundamental statistical measures in my field of population genetics. I held the journal and flipped through the article titles and familiar author names, realizing that my field wasn’t so far removed from the turn-of-the-century eugenics movement. Feeling somewhat nauseous, I photocopied the article I was looking for and returned the journal quickly.
Now as a faculty member at San Francisco State University (SFSU), a public institution that puts social justice at the center of its mission, I continue to struggle with my field’s limited reckoning with our eugenic past. Can folks like me, who have built careers that grow from eugenics science, hold ourselves accountable for these roots as we continue scientific research? These questions become increasingly important in a political landscape where scientific ideas about genetic variation and difference are weaponized to support devastating policies, and the atrocities of racial injustice...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Jessica Hamzelou, MIT Technology Review | 07.23.2026
When it comes to organ donation, time is everything. As soon as an organ has been carefully removed from a donor’s body, it starts to deteriorate. Surgeons have a matter of hours to get it into a recipient. Leave...
By Dhruv Mehrotra , Wired | 08.03.2026
On March 13, 2025, Hugo Moreno-Mendez arrived at the McLennan County Probation Department in Waco, Texas, expecting a routine probation check-in. Instead, Immigration and Customs Enforcement officers were waiting to arrest him.
According to a criminal complaint reviewed by WIRED...